The webinar will cover the 2019 MPFS and HOPPS final rules. We will review the content of the proposed rules and the CMS decisions on those proposals that were addressed in the final 2019 MPFS and HOPPS rules.

The webinar will cover the 2019 MPFS and HOPPS final rules and will take place on Wednesday, December 5, 2018 1:00-2:00 p.m. Eastern time.

On Tuesday, August 7, 2018, at 5:00 p.m. Eastern time, the August ASTRO-ARRO Journal Club webinar, Jason A. Efstathiou, MD, DPhil will be presenting on genitourinary cancers.  Dr.

This webinar will discuss contouring for gynecologic cancer cases. During this webinar, Dr. Lorraine Portelance, an expert in gynecologic cancers, will lead attendees through the key components of contouring.  Please join us on Thursday, June 28, 2018 5:00 p.m. – 6:00 p.m.

This webinar will discuss contouring for gynecologic cancer cases. During this webinar, Dr. Lorraine Portelance, an expert in gynecologic cancers, will lead attendees through the key components of contouring.  Please join us on Thursday, June 28, 2018 5:00 p.m. – 6:00 p.m.

This resident's webinar will discuss treatment planning for genitourinary cancer cases. Radiation oncology residents consistently report that plan evaluation is an aspect of residency training that is lacking. During this webinar, Dr.

This resident's webinar will discuss treatment planning for head and neck cancer cases. Radiation oncology residents consistently report that plan evaluation is an aspect of residency training that is lacking. During this webinar, Dr.

This resident's webinar will discuss treatment planning for breast cancer cases. Radiation oncology residents consistently report that plan evaluation is an aspect of residency training that is lacking. During this webinar, Dr.

This resident's webinar will discuss treatment planning for gynecological cancer cases. Radiation oncology residents consistently report that plan evaluation is an aspect of residency training that is lacking. During this webinar, Dr.

This resident's webinar will discuss NCCTG N107C which was a randomized phase III trial that evaluated the impact of WBRT and SRS to the resection cavity of a brain metastasis. This study, published late 2017, redefined the current national standard of care and NCCN guidelines.
 

Pages

Subscribe to RSS - Webinars